ABBV
AbbVie Inc.Company with tickers: ABBV
CIK
1551152
CUSIP
00287Y109
Shares Outstanding
1,766,792,821
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $15,002,000,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | $3,990,000,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Net Income | $695,000,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| EPS (Basic) | $0.39 | USD/shares | 2026-03-31 | 10-Q | 2026-05-08 |
| EPS (Diluted) | $0.39 | USD/shares | 2026-03-31 | 10-Q | 2026-05-08 |